Utpal Koppikar
Vermogen: 691 129 $ op 31-10-2026
Vermogen: 691 129 $ op 31-10-2026
Mr. Utpal Koppikar is an Independent Director at Insmed, Inc., a Chief Financial Officer at Verily Life Sciences LLC and an Independent Director at C4 Therapeutics, Inc. He is on the Board of Directors at Insmed, Inc. and C4 Therapeutics, Inc. Mr. Koppikar was previously employed as a Chief Financial Officer & Senior Vice President by Atara Biotherapeutics, Inc. and a Vice President-Corporate & Operations Finance by Gilead Sciences, Inc. He also served on the board at Flexion Therapeutics, Inc. He received his undergraduate degree from the University of Maryland, a graduate degree from Stanford University and an MBA from UCLA Anderson School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-10-2026 | 6.139 ( 0% ) | 691 129 $ | 31-10-2026 | |
| 24-06-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Bestuurslid | 16-03-2022 |
| INSMED INCORPORATED | Directeur/Bestuurslid | 20-10-2026 |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Financieel Directeur/CFO | 01-04-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Financieel Directeur/CFO | 31-03-2023 |
| FLEXION THERAPEUTICS, INC. | Directeur/Bestuurslid | 19-11-2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-06-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Technology Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau